re.Mind Capital

Alena uses neuroscience-based games to assess the user’s behaviour and identify thinking patterns that drive key mental health disorders. Using this deeper understanding, Alena suggests the most optimal intervention and dynamically adapts to the user's changing needs. Alena was founded in 2019 in London bringing together leading figures from the world of computational neuroscience, psychiatry and user-centric innovation. You can learn more about Alena on our website: www.alena.com

Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy aging and prolong lifespan.

OccamzRazor combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development. Our analysis pipeline consists of two proprietary technologies, Panoramic AI and RazorBrain. Together, they are designed to extract data from unstructured text sources (publications, patient reported outcomes, etc.) and join them with structured data (genomics, proteomics, phenomics, etc.) to generate stronger drug discovery hypotheses and more valuable insights. Successful applications include data extraction and curation from biomedical text, novel target identification, and drug repurposing/repositioning.

CereGate is a Brain-Machine Interface company establishing new ways of communication. CereGate has developed a system that allows the transmission of information directly into human consciousness. More precisely, CereGate is developing a groundbreaking computer-brain interface (CBI) technology. The platform enhances medical treatments by transmitting information directly to neural circuits using existing neuromodulation implants.

Neumora Therapeutics operates as a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience.

Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel neuroplasticity-promoting therapeutics—to better treat mental health disorders at scale. The company was founded in 2019 and is headquartered in Boston, Massachusetts.

TRIPP is a digital psychedelic wellness platform that uses the power of virtual and augmented reality. TRIPP creates advanced digital products that are based on scientific research and delivered through virtual reality, augmented reality, and mobile devices. TRIPP's platform is currently delivering wellness solutions to consumer households. It was founded in 2017 and headquartered in Los Angeles, California.

Ksana Health focuses on collecting data related to mental health and transferring that data from users to healthcare practitioners through an app. It was founded in 2019 and is based in Eugene, Oregon.

Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic.

Blackrock Neurotech’s mission is to provide innovative tools and neurotech expertise to translate technology into a novel, implantable clinical solutions that improve human lives.

CB Therapeutics is a biotech company that specializes in the biosynthetic production of cannabinoids from sugar. CB Therapeutics produces pure cannabinoids like CBD and THC using yeast and sugar. No plants involved.